It does not have to. It chooses to pay higher prices to """subsidize""" the research that is already paid for by my tax dollars, and to help pay for """developm

It does not have to. It chooses to pay higher prices to """subsidize""" the research that is already paid for by my tax dollars, and to help pay for """development""" that amounts to changing a drug from a mixture of both chiral versions to just the biologically active chiral compound, which somehow justifies another 25 years of monopoly for the exact same chemical. They could barely be bothered to change the name because they didn't want to lose brand mindshare.